Stock REPL REPLIMUNE GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Replimune Group, Inc.

Equities

REPL

US76029N1063

Market Closed - Nasdaq
Other stock markets
 04:00:08 2024-05-17 pm EDT 		5-day change 1st Jan Change
6.43 USD -4.32% Intraday chart for Replimune Group, Inc. +0.31% -23.72%
May. 16 Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Apr. 08 Replimune Group Provides Interim Results for Skin Cancer Therapy MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
REPLIMUNE GROUP, INC. Stock Replimune Group, Inc.
 396M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 50.93B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.12B
LONZA GROUP AG Stock Lonza Group AG
 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.02B
  1. Stock Market
  2. Equities
  3. REPL Stock
  4. Charts Replimune Group, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW